Attrition of Patients on a Precision Oncology Trial: Analysis of the I‐PREDICT Experience

BACKGROUND: Precision oncology uses molecular profiling of tumors to identify biomarker‐tailored therapies for patients in the hope of improving outcomes. Typically, only a minority of patients receives evaluable matched treatment. This study explored the reasons for attrition on a precision medicin...

Descripción completa

Detalles Bibliográficos
Autores principales: Bohan, Sandy S., Sicklick, Jason K., Kato, Shumei, Okamura, Ryosuke, Miller, Vincent A., Leyland‐Jones, Brian, Lippman, Scott M., Kurzrock, Razelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648352/
https://www.ncbi.nlm.nih.gov/pubmed/32949172
http://dx.doi.org/10.1002/onco.13532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648352/
https://www.ncbi.nlm.nih.gov/pubmed/32949172
http://dx.doi.org/10.1002/onco.13532

Ejemplares similares